Swiss Insurance Stock News

SWX:UBSG
SWX:UBSGCapital Markets

Is UBS Group (SWX:UBSG) Trading Legal Risks for Efficiency in Its India Expansion Strategy?

In recent days UBS Group has moved to reshape its operations, announcing plans to build out a new global capability centre in Hyderabad, India that is expected to hire close to 3,000 professionals, alongside workforce reductions in Switzerland linked to the Credit Suisse integration, while also facing a US$5.5 million arbitration payout to former client Kyle Blackmon. Together, this expansion of UBS’s technology and operations footprint in India and the legal setback in the Blackmon case...
SWX:LOGN
SWX:LOGNTech

How Logitech’s New Value Wireless Headset Launch At Logitech International (SWX:LOGN) Has Changed Its Investment Story

Earlier this month, Logitech International launched the Logitech G325 LIGHTSPEED Wireless Gaming Headset, a US$79.99 wireless device featuring LIGHTSPEED connectivity, 24-bit audio, and cross-platform support for PC, console, and mobile. By packaging higher-end wireless performance, software customization through G HUB, and AI-powered noise reduction into a lower-priced headset, Logitech is targeting value-conscious gamers who still want advanced features. We’ll now examine how this...
SWX:SCHN
SWX:SCHNMachinery

Schindler Holding (SWX:SCHN) Valuation After Strong 2025 Margin Beat Modernization Growth And Extra Dividend Proposal

Why Schindler Holding’s latest earnings matter for shareholders Schindler Holding (SWX:SCHN) has put fresh numbers on the table, reporting a 2025 EBIT margin of 12.6%, stronger modernization activity, and a proposed mix of regular and extraordinary dividends that directly affects shareholder cash returns. See our latest analysis for Schindler Holding. At a share price of CHF273.0, Schindler Holding has seen a 2.63% 1 day share price return after the earnings release, even though the 7 day...
SWX:NESN
SWX:NESNFood

Is Nestlé (SWX:NESN) Offering Opportunity After Mixed Long Term Share Performance

If you are wondering whether Nestlé at around CHF79.34 is offering fair value or a potential bargain, you are in the right place for a clear look at what that price really represents. The stock has returned 1.2% over the last 7 days and 5.5% over the last 30 days, although the 1 year return is a 1.8% decline and the 3 year return sits at a 19.3% decline, with a 7.9% decline over 5 years. Recent coverage has focused on how investors are reassessing large consumer staples companies like...
SWX:DKSH
SWX:DKSHTrade Distributors

A Look At DKSH Holding’s Valuation As The 2026 Earnings Release Puts Margins And Dividend Outlook In Focus

DKSH Holding (SWX:DKSH) heads into its 17 February 2026 earnings release with investors closely watching margins in Healthcare and Consumer Goods, alongside working capital metrics that could influence dividend expectations and near term sentiment. See our latest analysis for DKSH Holding. At a share price of CHF60.8, DKSH Holding has a 90 day share price return of 10.34%. Its 1 year total shareholder return of 10.59% and 3 year total shareholder return of 14.65% suggest recent momentum...
SWX:UBSG
SWX:UBSGCapital Markets

Is UBS Group (SWX:UBSG) Still Attractive After Credit Suisse Acquisition And Recent Share Pullback

If you are wondering whether UBS Group shares still offer value at current levels, you are not alone. This article is designed to help you weigh that up clearly. The stock last closed at CHF32.57, with returns of a 6.4% decline over 7 days, a 14.2% decline over 30 days and a 14.7% decline year to date, while the 1 year return sits at 12% and the 3 and 5 year returns are 74.5% and 166.5% respectively. Recent coverage has focused on UBS Group's role as a major global wealth manager and...
SWX:ROG
SWX:ROGPharmaceuticals

Assessing Roche Holding (SWX:ROG) Valuation After Fenebrutinib Progress And Data Analytics Push

Why fenebrutinib and data analytics matter for Roche Holding stock Roche Holding (SWX:ROG) has put fresh attention on its pipeline after reporting late stage data for its oral MS candidate fenebrutinib and highlighting new data analytics platforms in clinical development. For you as a shareholder or potential investor, these updates link directly to how Roche allocates R&D spending, manages clinical risk and builds potential future revenue sources beyond its currently marketed therapies. See...
SWX:UHR
SWX:UHRLuxury

Assessing Swatch Group (SWX:UHR) Valuation After Weak Earnings And Dividend Confirmation

Earnings setback and dividend affirmation come into focus Swatch Group (SWX:UHR) is in the spotlight after full year 2025 results showed sales of CHF 6,280 million and net income of CHF 3 million, alongside confirmation of an annual dividend of CHF 4.50 per share. See our latest analysis for Swatch Group. The annual results and dividend affirmation arrived alongside strong near term momentum, with a 1 day share price return of 2.43% and a 30 day share price return of 12.53%. However, the 3...
SWX:GALD
SWX:GALDPharmaceuticals

Galderma Group (SWX:GALD) Valuation Check After FDA Accepts RelabotulinumtoxinA BLA Resubmission

Galderma Group (SWX:GALD) is back in focus after the U.S. FDA accepted its BLA resubmission for RelabotulinumtoxinA, a neuromodulator targeting adult frown lines and crow's feet in the aesthetics market. See our latest analysis for Galderma Group. The FDA update follows a mixed price pattern, with a 1-day share price return of 1.84% and a 7-day share price return of 1.63%, offset by a 30-day share price return decline of 9.56% and a year-to-date share price return decline of 6.68%. The 1-year...
SWX:VACN
SWX:VACNMachinery

European Growth Companies With High Insider Ownership

Amidst recent market volatility, European indices like the STOXX Europe 600 have shown resilience, buoyed by optimism surrounding the eurozone economy. As investors navigate this landscape, growth companies with high insider ownership often attract attention due to their potential alignment of interests between management and shareholders, a factor that can be particularly appealing in times of economic uncertainty.
SWX:PGHN
SWX:PGHNCapital Markets

Assessing Partners Group Holding (SWX:PGHN) Valuation After New Private Markets SMA Launch

Why this new SMA launch matters for Partners Group Holding (SWX:PGHN) BlackRock and Partners Group Holding (SWX:PGHN) have introduced a multi alternatives separately managed account solution that packages private equity, private credit, and real assets access for financial advisors in a single, streamlined offering. See our latest analysis for Partners Group Holding. The new SMA launch comes after a weaker recent stretch for the shares, with a 7 day share price return showing a 6.49% decline...
SWX:ROG
SWX:ROGPharmaceuticals

Is Roche Holding (SWX:ROG) Pricing Reflect Recent 1 Year Rally And Cash Flow Outlook

If you have been wondering whether Roche Holding's current share price really lines up with its underlying worth, this article walks you through the key numbers that matter. Over the short term the stock has been relatively steady, with a 0.2% decline over the last 7 days. The 30 day, year to date and 1 year returns sit at 3.8%, 8.7% and 25.8% respectively, and the 3 year and 5 year figures are 41.4% and 33.3%. Recent coverage of Roche has focused on its position as a global healthcare group...
SWX:FHZN
SWX:FHZNInfrastructure

Assessing Flughafen Zürich (SWX:FHZN) Valuation After Executive Board Restructure And Leadership Changes

Executive reshuffle puts leadership focus back on core functions Flughafen Zürich (SWX:FHZN) has kicked off a broad management reshuffle, cutting its Executive Board from seven to six members and confirming the planned exit of Chief People & Communication Officer Manuela Staub in July 2026. See our latest analysis for Flughafen Zürich. At a share price of CHF249.6, Flughafen Zürich has seen a 4.44% 7 day share price return but a 4.22% 30 day share price decline. Its 1 year total shareholder...
SWX:UHR
SWX:UHRLuxury

Why Swatch Group (SWX:UHR) Is Up 8.1% After Holding Its Dividend Despite Weak 2025 Earnings

The Swatch Group AG recently reported full-year 2025 results, with sales of CHF 6,280 million and net income of CHF 3 million, and affirmed an annual dividend of CHF 4.50 per share payable on May 19, 2026. The decision to maintain the dividend despite much weaker profitability offers a clear signal about management’s confidence in the group’s financial resilience and priorities for rewarding shareholders. We will now examine how the earnings weakness paired with the affirmed dividend shapes...
SWX:GIVN
SWX:GIVNChemicals

Givaudan (SWX:GIVN) Valuation Check After Full Year Results And Dividend Announcement

Why Givaudan’s latest earnings and dividend matter for shareholders Givaudan (SWX:GIVN) has put fresh numbers on the table, pairing its full year 2025 earnings release with an annual dividend announcement that gives investors clearer insight into both cash returns and recent business performance. See our latest analysis for Givaudan. The latest earnings and dividend announcement comes after a mixed share price stretch, with a 7 day share price return of 3.58% but a 1 year total shareholder...